Astrocytoma

Astrocytomas are primary intracranial tumors derived from astrocytes cells of the brain. They may arise in the cerebral hemispheres, in the posterior fossa, in the optic nerve, and rarely, the spinal cord. The WHO has given a four point scale depending on the histologic grade of the tumor . This article focuses on the well-differentiated astrocytoma. For grade 1 and 4 astrocytomas, see respective article headings: (From the Wikpedia article Astrocytoma.)

Download PDF containing detailed information.

Recent Publications on Astrocytoma:
Factors Influencing Neurocognitive Outcomes in Young Patients with Benign and Low-Grade Brain Tumors Treated with Stereotactic Conformal Radiotherapy. PURPOSE: To present the effect of radiotherapy doses to different volumes...	30th October, 2009	Department of Radiation Oncology, Tata Memorial Centre, Mumbai, India.	Int J Radiat Oncol Biol Phys. 2009 Oct 26. DOI Direct Link
Concurrent sequence variation of TP53 and TP73 genes in anaplastic astrocytoma. Disruption or loss of tumor suppressor gene TP53 is implicated in the...	27th October, 2009	Departamento de Genetica, Laboratorio de Oncogenetica, Faculdade de	Genet Mol Res. 2009 Oct 20;8(4):1257-63. DOI Direct Link
Intrathecal liposomal cytarabine in combination with temozolomide in low-grade oligoastrocytoma with leptomeningeal dissemination. Leptomeningeal dissemination of low-grade gliomas is an uncommon event. A...	27th October, 2009	Division of Neurology, USSL 22, Via Ospedale 6, 37012, Bussolengo, Verona,	J Neurooncol. 2009 Oct 31. DOI Direct Link
Caspase-dependent generation of reactive oxygen species in human astrocytoma cells contributes to resistance to TRAIL-mediated apoptosis. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), a...	27th October, 2009	Department of Bio and Brain Engineering, KAIST, Daejeon, Korea.	Cell Death Differ. 2009 Oct 30. DOI Direct Link
Nonenhancing Intramedullary Astrocytomas and Other MR Imaging Features: A Retrospective Study and Systematic Review. BACKGROUND AND PURPOSE: Most intramedullary astrocytomas have been known...	27th October, 2009	Department of Radiology, Korea University Ansan Hospital, Kyunggi-do,	AJNR Am J Neuroradiol. 2009 Oct 29. DOI Direct Link
→View more research publications.

Press Releases About Astrocytoma:
Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements	2nd June, 2008	Antisense Pharma GmbH	CHICAGO and REGENSBURG, Germany, June 2 /PRNewswire/ -- "A two-year survival rate of more than 80 percent in recurrent or refractory anaplastic astrocytoma suggests a breakthrough in this

BioNews Results for Astrocytoma:
Caspase-dependent generation of reactive oxygen species in human astrocytoma cells contributes to resistance to TRAIL-mediated apoptosis	Cell Death and Differentiation:  Oct 30 2009 3:20PM Matching: astrocytoma
Mutation linked to pediatric brain tumor may pave way for targeted treatment	Washington University in St. Louis:  Oct 29 2009 10:24PM Matching: astrocytoma
Analysis of the mismatched manifestation between rCBF and rCBV maps in cerebral astrocytomas	Clinical Imaging:  Oct 28 2009 7:25AM Matching: astrocytoma
Health Canada approves Antisense Pharma's clinical Phase III study SAPPHIRE in aggressive brain tumors	Pharma Live:  Oct 20 2009 7:32AM Matching: astrocytoma
HK reports 32nd A/H1N1 flu death case	CHINAdaily:  Oct 20 2009 3:57PM Matching: astrocytoma
Promote your company here: BioNewsCast - Press Release Distribution	→View more news.

Astrocytoma Clinical Trials:
Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas

Astrocytoma Patents:
US Patent No.	Title
7589119	Methods for treating or preventing metastatic cancer using benzopyranone compounds
7595320	Hydrazinocarbonyl-thieno[2,3-C]pyrazoles, process for preparing them, compositions containing them and use thereof
7595332	Amides that inhibit vanilloid receptor subtype 1 (VR1)
7595337	Mitotic kinesin inhibitors
7597884	Hyperglycosylated polypeptide variants and methods of use
→View more patents.

Companies working in the area of Astrocytoma from Bioportfolio's Biocorporate database :
Company Name
Protox Therapeutics Inc. Protox Therapeutics is a product-focused development-stage company and a leader in advancing novel, targeted protein toxin therapeutics for the treatment of cancer and other proliferative diseases.... www.protoxtherapeutics.com/        View full profile

BioPortfolio Ltd. offers e-mail and postal lists for Astrocytoma scientists - we have details of around 1338 individuals working on Astrocytoma .